BIOCRYST PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Earnings Per Share, Basic and Diluted of -$1030.00 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-02-28
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$330.00.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$240.00.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.36.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.34.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2021 was -$1030.00.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2020 was -$1090.00.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2019 was -$940.00.
- BIOCRYST PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.98.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$1030.00 10-K · filed 2022-02-28 | |||||||
| 2021-09-30 | -$330.00 10-Q · filed 2021-11-04 | -$930.00 10-Q · filed 2021-11-04 | ||||||
| 2021-06-30 | -$240.00 10-Q · filed 2021-08-09 | -$600.00 10-Q · filed 2021-08-09 | ||||||
| 2021-03-31 | -$0.36 10-Q · filed 2021-05-07 | |||||||
| 2020-12-31 | -$0.34 10-K · filed 2021-03-01 | -$1090.00 10-K · filed 2022-02-28 | -$1.09 10-K · filed 2021-03-01 | |||||
| 2020-09-30 | -$260.00 10-Q · filed 2021-11-04 | -$0.26 10-Q · filed 2020-11-06 | -$750.00 10-Q · filed 2021-11-04 | -$0.75 10-Q · filed 2020-11-06 | ||||
| 2020-06-30 | -$240.00 10-Q · filed 2021-08-09 | -$0.24 10-Q · filed 2020-08-07 | -$480.00 10-Q · filed 2021-08-09 | -$0.48 10-Q · filed 2020-08-07 | ||||
| 2020-03-31 | -$0.24 10-Q · filed 2021-05-07 | |||||||
| 2019-12-31 | -$0.02 10-K · filed 2021-03-01 | -$940.00 10-K · filed 2022-02-28 | -$0.94 10-K · filed 2020-03-13 | |||||
| 2019-09-30 | -$0.34 10-K · filed 2021-03-01 | -$0.96 10-Q · filed 2020-11-06 | ||||||
| 2019-06-30 | -$0.34 10-K · filed 2021-03-01 | -$0.62 10-Q · filed 2020-08-07 | ||||||
| 2019-03-31 | -$0.28 10-K · filed 2021-03-01 | |||||||
| 2018-12-31 | -$0.25 10-K · filed 2020-03-13 | -$0.98 10-K · filed 2021-03-01 | ||||||
| 2018-09-30 | -$0.28 10-K · filed 2020-03-13 | -$0.73 10-Q · filed 2019-11-08 | ||||||
| 2018-06-30 | -$0.19 10-K · filed 2020-03-13 | -$0.45 10-Q · filed 2019-08-08 | ||||||
| 2018-03-31 | -$0.26 10-K · filed 2020-03-13 | |||||||
| 2017-12-31 | -$0.20 10-K · filed 2019-03-14 | -$0.78 10-K · filed 2020-03-13 | ||||||
| 2017-09-30 | -$0.18 10-K · filed 2019-03-14 | -$0.58 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | -$0.21 10-K · filed 2019-03-14 | -$0.40 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | -$0.19 10-K · filed 2019-03-14 | |||||||
| 2016-12-31 | -$0.06 10-K · filed 2018-03-12 | -$0.75 10-K · filed 2019-03-14 | ||||||
| 2016-09-30 | -$0.16 10-K · filed 2018-03-12 | -$0.69 10-Q · filed 2017-11-08 | ||||||
| 2016-06-30 | -$0.22 10-K · filed 2018-03-12 | -$0.53 10-Q · filed 2017-08-08 | ||||||
| 2016-03-31 | -$0.31 10-K · filed 2018-03-12 | |||||||
| 2015-12-31 | -$0.59 10-K · filed 2018-03-12 | |||||||
| 2015-09-30 | -$0.20 10-Q · filed 2016-11-08 | -$0.34 10-Q · filed 2016-11-08 | ||||||
| 2015-03-31 | -$0.21 10-Q · filed 2016-05-09 | |||||||
| 2014-12-31 | -$0.16 10-K · filed 2016-02-26 | -$0.68 10-K · filed 2017-02-27 | ||||||
| 2014-09-30 | -$0.12 10-K · filed 2016-02-26 | -$0.52 10-Q · filed 2015-11-06 | ||||||
| 2014-06-30 | -$0.23 10-K · filed 2016-02-26 | -$0.40 10-Q · filed 2014-08-08 | ||||||
| 2014-03-31 | -$0.17 10-K · filed 2016-02-26 | |||||||
| 2013-12-31 | -$0.09 10-K · filed 2015-03-02 | -$0.55 10-K · filed 2016-02-26 | ||||||
| 2013-09-30 | -$0.14 10-K · filed 2015-03-02 | -$0.46 10-Q · filed 2014-11-07 | ||||||
| 2013-06-30 | -$0.23 10-K · filed 2015-03-02 | -$0.32 10-Q · filed 2014-08-08 | ||||||
| 2013-03-31 | -$0.09 10-K · filed 2015-03-02 | |||||||
| 2012-12-31 | -$0.22 10-K · filed 2014-03-10 | -$0.79 10-K · filed 2015-03-02 | ||||||
| 2012-09-30 | -$0.19 10-K · filed 2014-03-10 | -$0.57 10-Q · filed 2013-11-08 | ||||||
| 2012-06-30 | -$0.25 10-K · filed 2014-03-10 | -$0.38 10-Q · filed 2013-08-08 | ||||||
| 2012-03-31 | -$0.13 10-K · filed 2014-03-10 | |||||||
| 2011-12-31 | -$0.29 10-K · filed 2013-03-11 | -$1.26 10-K · filed 2014-03-10 | ||||||
| 2011-09-30 | -$0.32 10-K · filed 2013-03-11 | -$0.97 10-Q · filed 2012-11-08 | ||||||
| 2011-06-30 | -$0.36 10-K · filed 2013-03-11 | -$0.65 10-Q · filed 2012-08-08 | ||||||
| 2011-03-31 | -$0.29 10-K · filed 2013-03-11 | |||||||
| 2010-12-31 | -$0.76 10-K · filed 2013-03-11 | |||||||
| 2010-09-30 | -$0.24 10-Q · filed 2011-11-03 | -$0.53 10-Q · filed 2011-11-03 | ||||||
| 2010-06-30 | -$0.23 10-Q · filed 2011-08-04 | -$0.29 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | -$0.35 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |